Article
Derivation of an induced pluripotent stem cell line from a long QT syndrome type 1 patient with a pathogenic KCNQ1 c.1552C > T (p.Arg518Ter) variant.
Stem cell research - 1 Aug 2026
Ding Dingqian, Choi Jonathan, Gollatz Elisa Marie, Harbuzariu Adriana, Itzhaki Ilanit
Abstract excerpt
Long QT syndrome type 1 (LQT1) arises from mutations in the KCNQ1 gene that diminish the slow delayed rectifier potassium current (IKs), leading to a prolonged action potential duration in cardiomyocytes and a prolonged QT interval clinically. LQT1 patients can develop proarrhythmic symptoms that can manifest as seizures, syncope, cardiac arrest, or sudden death. An iPSC line was derived from an LQT1 patient with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
